Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026)
Ovid Therapeutics' (OVID) quarterly Other Working Capital Changes came in at -$349000.0 in Q1 2026, down 7.38% YoY from -$376827.2 in Q1 2025, and down 2.05% on a QoQ basis from -$342000.0 in Q4 2025.
Ovid Therapeutics (OVID) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has 5 years of Other Working Capital Changes data on file, last reported at -$349000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 7.38% year-over-year to -$349000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 7.26% YoY) and the FY2025 annual result came in at -$1.3 million, down 7.22% from the prior year.
- Other Working Capital Changes slipped to -$349000.0 in Q1 2026, from -$342000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.3 million in Q2 2023 to a low of -$1.8 million in Q3 2023.
- A 5-year average of $121688.7 and a median of -$151000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes tumbled 224.75% — and 2024, when it surged 61.28%.
- Tracing OVID's Other Working Capital Changes over 5 years: stood at $286838.0 in 2022, then plunged by 203.19% to -$296000.0 in 2023, then decreased by 8.11% to -$320000.0 in 2024, then slipped by 6.88% to -$342000.0 in 2025, then retreated by 2.05% to -$349000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$349000.0 (Q1 2026), -$342000.0 (Q4 2025), and -$337000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | -160,000.00 |
| Sep 30, 2025 | -160,000.00 |
| Sep 30, 2025 | -160,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Jun 30, 2025 | 818,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Dec 31, 2024 | -899,000.00 |
| Sep 30, 2024 | -151,000.00 |
| Sep 30, 2024 | -151,000.00 |